Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.000
0.00 (0.00%)
At close: May 9, 2025, 4:00 PM
3.140
+0.140 (4.67%)
After-hours: May 9, 2025, 6:18 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $514.33 million as of May 9, 2025. Its market cap has decreased by -34.13% in one year.
Market Cap
514.33M
Enterprise Value
-148.86M
1-Year Change
-34.13%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $514.33M, a decrease of -83.05%. That is a compound annual growth rate of -30.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 514.33M | -25.42% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.68B |
| Johnson & Johnson | 379.94B |
| UnitedHealth Group | 354.08B |
| AbbVie | 336.23B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.49B |
| Novartis AG | 220.92B |
| AstraZeneca | 217.30B |